Preparing for Patient-Centric Drug Development Regulations

Dr Jamie Unwin is the Commercial Insight Officer at Nanoform, an innovative nanoparticle medicine-enabling company.  A passionate advocate for patient centricity as a “North Star” for new drug development, Jamie’s role is to help clients understand the value Nanoform’s services and solutions can bring to their individual drug candidates, and portfolios as a whole.  A twenty-year pharma industry veteran, Jamie and his teams have provided Insights to maximise patient, physician, and payer access to twenty three new drug launches.  Jamie is a recognised opinion leader in the Business Insight world, and has held senior roles at GlaxoSmithKline, GE Healthcare, Janssen (Pharmaceutical Companies of Johnson and Johnson) and most recently was VP Enterprise Insights for Biocon Biologics.  In addition to his role at Nanoform, Jamie is also visiting lecturer at Imperial College Business School (London, UK) where he teaches classes on advanced analytics in healthcare.

Hannah Mann has over 20 years’ experience as a market insight expert, working with big pharma clients to bring the voice of the customer to the heart of decision making.   In March 2019 Hannah decided to co-found Day One Strategy with the ambition of partnering with forward thinking clients to help develop modern healthcare brands that truly meet the needs of today’s customer. Hannah has also served as a judge for the annual EphMRA awards, presented at MRS and EphMRA conferences and written a number of successful blogs on women in leadership.  In 2021 Hannah also launched The Day One Room 101 podcast that brings together leaders in the field of market research to discuss their pet hates and future predictions for our industry. Her passion projects have included working with the Princes Trust to help provide opportunities for underprivileged young adults and mentoring young female execs looking to grow in their careers whilst balancing work with family life.

Mike is CEO and Founder of IDEA Pharma and Protodigm. He is a pharma innovation protagonist, antagonist, and geek. Mike is the author of “Positioning Pharmaceuticals” and a contributor to Fortune, STAT, and Endpoints. He is recognized as an industry influencer — Global Power List: 20 in 2020 and 2021, the Top 20 inspirational medicine makers in biopharmaceuticals (The Medicine Maker); Top 10 Innovators in Pharma (PharmaPhorum); PharmaVOICE Red Jacket: 100 Most Inspiring People in Healthcare (2011, '13, '15 and '16, + lifetime Red Jacket winner); and Global Power List 100 (Medicine Maker, the 100 most influential people in healthcare, 2017, 2018, 2019). Mike is also a Senior Fellow at the Milken Institute, and an advisor to BioEthics International.

 

Twinkle Christian is a Process Development Scientist at Amgen. She has 15+ years of industry experience in formulation development across diverse modalities and has led the advancement of multiple programs from early discovery to clinical trials and commercialization. Twinkle’s expertise encompasses high concentration formulation and drug delivery of biologics, investigating protein-protein interactions, and macromolecular crystallography. She is an adjunct instructor at California State University, Channel Islands & University of California, Santa Barbara. Twinkle holds a Master’s in Biochemistry and Molecular Biology and was employed at Alza (Johnson & Johnson) and VaxGen prior to Amgen.

Yasmine Gomaa is a Senior Research Scientist and the Associate Director of the Laboratory of Drug Delivery at Georgia Institute of Technology, Atlanta, Georgia since April 2021. She earned a BA, MD and Ph D degrees in Pharmaceutical Sciences from Faculty of Pharmacy, Alexandria University, Egypt. Her research experience over the past 20 years has been in the delivery of drugs, vaccines and cosmeceuticals, especially via the transdermal and topical route. Early in her research career, she utilized drug delivery systems for skin delivery and recently microneedle based systems for skin and transdermal delivery of drugs and vaccines. She has a strong publication record, is a co-inventor for two pending patents and co-wrote several successful grants. She has worked in collaboration with industry, academic institutions, and several governmental, private and regulatory agencies as well as organizations such as CDC, WHO, UNICEF and Bill and Melinda Gates Foundation.